Murielle Veniant-Ellison
Company: Amgen
Job title: Scientific Vice President
Seminars:
Targeting GLP-1R & GIPR in a Novel Biospecific Mechanism to Advance a Longer-Acting Therapy for Weight-Loss 9:30 am
Synergistic effects on weight loss and metabolic parameters in preclinical obese models Balancing durability, efficacy and safety to attain significant reduction in body weight Demonstrating competitive advantage with a first-in-class mechanism in Phase 1 and beyond and advancing a Phase 2 dose-ranging trials to demonstrate significant and durable weight lossRead more
day: Conference Day 1